Page last updated: 2024-10-28

glipizide and Chagas Disease

glipizide has been researched along with Chagas Disease in 1 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Juárez-Saldivar, A1
Schroeder, M1
Salentin, S1
Haupt, VJ1
Saavedra, E1
Vázquez, C1
Reyes-Espinosa, F1
Herrera-Mayorga, V1
Villalobos-Rocha, JC1
García-Pérez, CA1
Campillo, NE1
Rivera, G1

Other Studies

1 other study available for glipizide and Chagas Disease

ArticleYear
Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling.
    International journal of molecular sciences, 2020, Jun-16, Volume: 21, Issue:12

    Topics: Chagas Disease; Computer Simulation; Drug Repositioning; Folic Acid Antagonists; Glipizide; Glyburid

2020